La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both

Identifieur interne : 000687 ( PascalFrancis/Curation ); précédent : 000686; suivant : 000688

Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both

Auteurs : Cameron C. Mcintyre [États-Unis] ; Marc Savasta [France] ; Lydia Kerkerian-Le Goff [France] ; Jerrold L. Vitek [États-Unis]

Source :

RBID : Pascal:04-0604031

Descripteurs français

English descriptors

Abstract

High-frequency deep brain stimulation (DBS) of the thalamus or basal ganglia represents an effective clinical technique for the treatment of several medically refractory movement disorders. However, understanding of the mechanisms responsible for the therapeutic action of DBS remains elusive. The goal of this review is to address our present knowledge of the effects of high-frequency stimulation within the central nervous system and comment on the functional implications of this knowledge for uncovering the mechanism(s) of DBS. Four general hypotheses have been developed to explain the mechanism(s) of DBS: depolarization blockade, synaptic inhibition, synaptic depression, and stimulation-induced modulation of pathological network activity. Using the results from functional imaging, neurochemistry, neural recording, and neural modeling experiments we address the general hypotheses and attempt to reconcile what have been considered conflicting results from these different research modalities. Our analysis suggests stimulation-induced modulation of pathological network activity represents the most likely mechanism of DBS; however, several open questions remain to explicitly link the effects of DBS with therapeutic outcomes.
pA  
A01 01  1    @0 1388-2457
A03   1    @0 Clin. neurophysiol.
A05       @2 115
A06       @2 6
A08 01  1  ENG  @1 Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both
A11 01  1    @1 MCINTYRE (Cameron C.)
A11 02  1    @1 SAVASTA (Marc)
A11 03  1    @1 KERKERIAN-LE GOFF (Lydia)
A11 04  1    @1 VITEK (Jerrold L.)
A14 01      @1 Department of Neurology, Emory University School of Medicine, Woodruff Memorial Research Building, Suite 6000, 1639 Pierce Drive @2 Atlanta, GA 30322 @3 USA @Z 1 aut. @Z 4 aut.
A14 02      @1 Neurochimie et Neuroplastisté Fonctionnelles, INSERM U318, Université Joseph Fourier, CHU de Grenoble, Departement de Neurologie, BP 217 @2 38043 Grenoble @3 FRA @Z 2 aut.
A14 03      @1 Laboratoire de Neurobiologie Cellulaire et Fonctionnelle, CNRS, 31 Chemin Joseph Aiguier @2 13402 Marseille @3 FRA @Z 3 aut.
A20       @1 1239-1248
A21       @1 2004
A23 01      @0 ENG
A43 01      @1 INIST @2 5626E @5 354000110073830010
A44       @0 0000 @1 © 2004 INIST-CNRS. All rights reserved.
A45       @0 1 p.3/4
A47 01  1    @0 04-0604031
A60       @1 P
A61       @0 A
A64 01  1    @0 Clinical neurophysiology
A66 01      @0 IRL
C01 01    ENG  @0 High-frequency deep brain stimulation (DBS) of the thalamus or basal ganglia represents an effective clinical technique for the treatment of several medically refractory movement disorders. However, understanding of the mechanisms responsible for the therapeutic action of DBS remains elusive. The goal of this review is to address our present knowledge of the effects of high-frequency stimulation within the central nervous system and comment on the functional implications of this knowledge for uncovering the mechanism(s) of DBS. Four general hypotheses have been developed to explain the mechanism(s) of DBS: depolarization blockade, synaptic inhibition, synaptic depression, and stimulation-induced modulation of pathological network activity. Using the results from functional imaging, neurochemistry, neural recording, and neural modeling experiments we address the general hypotheses and attempt to reconcile what have been considered conflicting results from these different research modalities. Our analysis suggests stimulation-induced modulation of pathological network activity represents the most likely mechanism of DBS; however, several open questions remain to explicitly link the effects of DBS with therapeutic outcomes.
C02 01  X    @0 002B17G
C02 02  X    @0 002B17H
C02 03  X    @0 002B17A01
C03 01  X  FRE  @0 Mécanisme action @5 01
C03 01  X  ENG  @0 Mechanism of action @5 01
C03 01  X  SPA  @0 Mecanismo acción @5 01
C03 02  X  FRE  @0 Inhibition synaptique @5 02
C03 02  X  ENG  @0 Synaptic inhibition @5 02
C03 02  X  SPA  @0 Inhibición sináptico @5 02
C03 03  X  FRE  @0 Haute fréquence @5 03
C03 03  X  ENG  @0 High frequency @5 03
C03 03  X  SPA  @0 Alta frecuencia @5 03
C03 04  X  FRE  @0 Thalamus @5 04
C03 04  X  ENG  @0 Thalamus @5 04
C03 04  X  SPA  @0 Tálamo @5 04
C03 05  X  FRE  @0 Noyau gris central @5 05
C03 05  X  ENG  @0 Basal ganglion @5 05
C03 05  X  SPA  @0 Núcleo basal @5 05
C03 06  X  FRE  @0 Technique @5 06
C03 06  X  ENG  @0 Technique @5 06
C03 06  X  SPA  @0 Técnica @5 06
C03 07  X  FRE  @0 Parkinson maladie @5 09
C03 07  X  ENG  @0 Parkinson disease @5 09
C03 07  X  SPA  @0 Parkinson enfermedad @5 09
C03 08  X  FRE  @0 Tremblement @5 12
C03 08  X  ENG  @0 Tremor @5 12
C03 08  X  SPA  @0 Temblor @5 12
C03 09  X  FRE  @0 Dépolarisation @5 13
C03 09  X  ENG  @0 Depolarization @5 13
C03 09  X  SPA  @0 Despolarización @5 13
C03 10  X  FRE  @0 Dépression synaptique @5 14
C03 10  X  ENG  @0 Synaptic depression @5 14
C03 10  X  SPA  @0 Depresión sináptica @5 14
C03 11  X  FRE  @0 Traitement instrumental @5 57
C03 11  X  ENG  @0 Instrumentation therapy @5 57
C03 11  X  SPA  @0 Tratamiento instrumental @5 57
C03 12  X  FRE  @0 Dystonie @5 58
C03 12  X  ENG  @0 Dystonia @5 58
C03 12  X  SPA  @0 Distonía @5 58
C03 13  X  FRE  @0 Contrôle moteur @5 69
C03 13  X  ENG  @0 Motor control @5 69
C03 13  X  SPA  @0 Control motor @5 69
C03 14  X  FRE  @0 Stimulation cérébrale profonde @4 CD @5 96
C03 14  X  ENG  @0 Deep brain stimulation @4 CD @5 96
C07 01  X  FRE  @0 Encéphale pathologie @5 20
C07 01  X  ENG  @0 Cerebral disorder @5 20
C07 01  X  SPA  @0 Encéfalo patología @5 20
C07 02  X  FRE  @0 Transmission synaptique @5 21
C07 02  X  ENG  @0 Synaptic transmission @5 21
C07 02  X  SPA  @0 Transmisión sináptica @5 21
C07 03  X  FRE  @0 Système nerveux pathologie @5 22
C07 03  X  ENG  @0 Nervous system diseases @5 22
C07 03  X  SPA  @0 Sistema nervioso patología @5 22
C07 04  X  FRE  @0 Extrapyramidal syndrome @5 23
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 23
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 23
C07 05  X  FRE  @0 Maladie dégénérative @5 24
C07 05  X  ENG  @0 Degenerative disease @5 24
C07 05  X  SPA  @0 Enfermedad degenerativa @5 24
C07 06  X  FRE  @0 Système nerveux central pathologie @5 25
C07 06  X  ENG  @0 Central nervous system disease @5 25
C07 06  X  SPA  @0 Sistema nervosio central patología @5 25
C07 07  X  FRE  @0 Mouvement involontaire @5 26
C07 07  X  ENG  @0 Involuntary movement @5 26
C07 07  X  SPA  @0 Movimiento involuntario @5 26
C07 08  X  FRE  @0 Trouble neurologique @5 27
C07 08  X  ENG  @0 Neurological disorder @5 27
C07 08  X  SPA  @0 Trastorno neurológico @5 27
C07 09  X  FRE  @0 Muscle strié pathologie @5 28
C07 09  X  ENG  @0 Striated muscle disease @5 28
C07 09  X  SPA  @0 Músculo estriado patología @5 28
N21       @1 348

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:04-0604031

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both</title>
<author>
<name sortKey="Mcintyre, Cameron C" sort="Mcintyre, Cameron C" uniqKey="Mcintyre C" first="Cameron C." last="Mcintyre">Cameron C. Mcintyre</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Emory University School of Medicine, Woodruff Memorial Research Building, Suite 6000, 1639 Pierce Drive</s1>
<s2>Atlanta, GA 30322</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Savasta, Marc" sort="Savasta, Marc" uniqKey="Savasta M" first="Marc" last="Savasta">Marc Savasta</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Neurochimie et Neuroplastisté Fonctionnelles, INSERM U318, Université Joseph Fourier, CHU de Grenoble, Departement de Neurologie, BP 217</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Kerkerian Le Goff, Lydia" sort="Kerkerian Le Goff, Lydia" uniqKey="Kerkerian Le Goff L" first="Lydia" last="Kerkerian-Le Goff">Lydia Kerkerian-Le Goff</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Laboratoire de Neurobiologie Cellulaire et Fonctionnelle, CNRS, 31 Chemin Joseph Aiguier</s1>
<s2>13402 Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vitek, Jerrold L" sort="Vitek, Jerrold L" uniqKey="Vitek J" first="Jerrold L." last="Vitek">Jerrold L. Vitek</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Emory University School of Medicine, Woodruff Memorial Research Building, Suite 6000, 1639 Pierce Drive</s1>
<s2>Atlanta, GA 30322</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">04-0604031</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0604031 INIST</idno>
<idno type="RBID">Pascal:04-0604031</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D47</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000687</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both</title>
<author>
<name sortKey="Mcintyre, Cameron C" sort="Mcintyre, Cameron C" uniqKey="Mcintyre C" first="Cameron C." last="Mcintyre">Cameron C. Mcintyre</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Emory University School of Medicine, Woodruff Memorial Research Building, Suite 6000, 1639 Pierce Drive</s1>
<s2>Atlanta, GA 30322</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Savasta, Marc" sort="Savasta, Marc" uniqKey="Savasta M" first="Marc" last="Savasta">Marc Savasta</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Neurochimie et Neuroplastisté Fonctionnelles, INSERM U318, Université Joseph Fourier, CHU de Grenoble, Departement de Neurologie, BP 217</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Kerkerian Le Goff, Lydia" sort="Kerkerian Le Goff, Lydia" uniqKey="Kerkerian Le Goff L" first="Lydia" last="Kerkerian-Le Goff">Lydia Kerkerian-Le Goff</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Laboratoire de Neurobiologie Cellulaire et Fonctionnelle, CNRS, 31 Chemin Joseph Aiguier</s1>
<s2>13402 Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vitek, Jerrold L" sort="Vitek, Jerrold L" uniqKey="Vitek J" first="Jerrold L." last="Vitek">Jerrold L. Vitek</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Department of Neurology, Emory University School of Medicine, Woodruff Memorial Research Building, Suite 6000, 1639 Pierce Drive</s1>
<s2>Atlanta, GA 30322</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Clinical neurophysiology</title>
<title level="j" type="abbreviated">Clin. neurophysiol.</title>
<idno type="ISSN">1388-2457</idno>
<imprint>
<date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Clinical neurophysiology</title>
<title level="j" type="abbreviated">Clin. neurophysiol.</title>
<idno type="ISSN">1388-2457</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Basal ganglion</term>
<term>Deep brain stimulation</term>
<term>Depolarization</term>
<term>Dystonia</term>
<term>High frequency</term>
<term>Instrumentation therapy</term>
<term>Mechanism of action</term>
<term>Motor control</term>
<term>Parkinson disease</term>
<term>Synaptic depression</term>
<term>Synaptic inhibition</term>
<term>Technique</term>
<term>Thalamus</term>
<term>Tremor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Mécanisme action</term>
<term>Inhibition synaptique</term>
<term>Haute fréquence</term>
<term>Thalamus</term>
<term>Noyau gris central</term>
<term>Technique</term>
<term>Parkinson maladie</term>
<term>Tremblement</term>
<term>Dépolarisation</term>
<term>Dépression synaptique</term>
<term>Traitement instrumental</term>
<term>Dystonie</term>
<term>Contrôle moteur</term>
<term>Stimulation cérébrale profonde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">High-frequency deep brain stimulation (DBS) of the thalamus or basal ganglia represents an effective clinical technique for the treatment of several medically refractory movement disorders. However, understanding of the mechanisms responsible for the therapeutic action of DBS remains elusive. The goal of this review is to address our present knowledge of the effects of high-frequency stimulation within the central nervous system and comment on the functional implications of this knowledge for uncovering the mechanism(s) of DBS. Four general hypotheses have been developed to explain the mechanism(s) of DBS: depolarization blockade, synaptic inhibition, synaptic depression, and stimulation-induced modulation of pathological network activity. Using the results from functional imaging, neurochemistry, neural recording, and neural modeling experiments we address the general hypotheses and attempt to reconcile what have been considered conflicting results from these different research modalities. Our analysis suggests stimulation-induced modulation of pathological network activity represents the most likely mechanism of DBS; however, several open questions remain to explicitly link the effects of DBS with therapeutic outcomes.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1388-2457</s0>
</fA01>
<fA03 i2="1">
<s0>Clin. neurophysiol.</s0>
</fA03>
<fA05>
<s2>115</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MCINTYRE (Cameron C.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SAVASTA (Marc)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>KERKERIAN-LE GOFF (Lydia)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>VITEK (Jerrold L.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Emory University School of Medicine, Woodruff Memorial Research Building, Suite 6000, 1639 Pierce Drive</s1>
<s2>Atlanta, GA 30322</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Neurochimie et Neuroplastisté Fonctionnelles, INSERM U318, Université Joseph Fourier, CHU de Grenoble, Departement de Neurologie, BP 217</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Laboratoire de Neurobiologie Cellulaire et Fonctionnelle, CNRS, 31 Chemin Joseph Aiguier</s1>
<s2>13402 Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>1239-1248</s1>
</fA20>
<fA21>
<s1>2004</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>5626E</s2>
<s5>354000110073830010</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 p.3/4</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>04-0604031</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Clinical neurophysiology</s0>
</fA64>
<fA66 i1="01">
<s0>IRL</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>High-frequency deep brain stimulation (DBS) of the thalamus or basal ganglia represents an effective clinical technique for the treatment of several medically refractory movement disorders. However, understanding of the mechanisms responsible for the therapeutic action of DBS remains elusive. The goal of this review is to address our present knowledge of the effects of high-frequency stimulation within the central nervous system and comment on the functional implications of this knowledge for uncovering the mechanism(s) of DBS. Four general hypotheses have been developed to explain the mechanism(s) of DBS: depolarization blockade, synaptic inhibition, synaptic depression, and stimulation-induced modulation of pathological network activity. Using the results from functional imaging, neurochemistry, neural recording, and neural modeling experiments we address the general hypotheses and attempt to reconcile what have been considered conflicting results from these different research modalities. Our analysis suggests stimulation-induced modulation of pathological network activity represents the most likely mechanism of DBS; however, several open questions remain to explicitly link the effects of DBS with therapeutic outcomes.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17H</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B17A01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Mécanisme action</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Mechanism of action</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Mecanismo acción</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Inhibition synaptique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Synaptic inhibition</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Inhibición sináptico</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Haute fréquence</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>High frequency</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Alta frecuencia</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Thalamus</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Thalamus</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Tálamo</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Noyau gris central</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Basal ganglion</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Núcleo basal</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Technique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Technique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Técnica</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Tremblement</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Tremor</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Temblor</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Dépolarisation</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Depolarization</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Despolarización</s0>
<s5>13</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Dépression synaptique</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Synaptic depression</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Depresión sináptica</s0>
<s5>14</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Traitement instrumental</s0>
<s5>57</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Instrumentation therapy</s0>
<s5>57</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Tratamiento instrumental</s0>
<s5>57</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Dystonie</s0>
<s5>58</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Dystonia</s0>
<s5>58</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Distonía</s0>
<s5>58</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Contrôle moteur</s0>
<s5>69</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Motor control</s0>
<s5>69</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Control motor</s0>
<s5>69</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Stimulation cérébrale profonde</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Deep brain stimulation</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>20</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>20</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>20</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Transmission synaptique</s0>
<s5>21</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Synaptic transmission</s0>
<s5>21</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Transmisión sináptica</s0>
<s5>21</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>22</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>22</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>22</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>23</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>23</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>23</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>24</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>24</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>24</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>25</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>25</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>25</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>26</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>26</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>26</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>27</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>27</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>27</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Muscle strié pathologie</s0>
<s5>28</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Striated muscle disease</s0>
<s5>28</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Músculo estriado patología</s0>
<s5>28</s5>
</fC07>
<fN21>
<s1>348</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000687 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000687 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:04-0604031
   |texte=   Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024